Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

Saved in:
Bibliographic Details
Author / Creator:Jaggar, Sarah F.
Imprint:Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1996]
Description:8 pages ; 28 cm.
Language:English
Series:Testimony ; GAO/T-HEHS-96-216
Testimony ; GAO/T-HEHS-96-216.
Subject:
Drugstores -- United States.
Drugs -- Prices -- United States.
Prescription pricing -- United States.
Format: E-Resource U.S. Federal Government Document Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/6509672
Hidden Bibliographic Details
Varying Form of Title:Implications for retail pharmacies
Other authors / contributors:United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
United States. General Accounting Office.
Notes:"September 19, 1996."
Not distributed to depository libraries in a physical form.
Includes bibliographical references.
Available via Internet from the GPO Access web site. Address as of 5/21/2001: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:he96216t.pdf; current access is available via PURL.
GPO item no.:0546-D-01 (online)
Govt.docs classification:GA 1.5/2:T-HEHS-96-216

Similar Items